Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients-Reference-Cited by-同舟云学术

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

Published:2018-11-16 Issue:90 Volume:9 Page:36238-36249
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Long-Mira Elodie¹²³,Ilie Marius¹²³,Chamorey Emmanuel⁴,Leduff-Blanc Florence⁵,Montaudié Henri⁵,Tanga Virginie³,Allégra Maryline³,Lespinet-Fabre Virginie³,Bordone Olivier³,Bonnetaud Christelle³,Schiappa Renaud⁴,Butori Catherine¹,Bence Coraline¹,Lacour Jean-Philippe⁵,Hofman Véronique¹²³,Hofman Paul¹²³

Affiliation:

1. Université Côte d'Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France

2. Université Côte d'Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Team 4, Nice, France

3. Université Côte d'Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank, Nice, France

4. Antoine Lacassagne Comprehensive Cancer Center, FHU OncoAge, Biostatistics Unit, Nice, France

5. Université Côte d'Azur, CHU Nice, Department of Dermatology, Archet Hospital, Nice, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No BRAF p.V600E mutation detection in ameloblastoma liquid biopsy-based analysis by ddPCR;Oral Oncology;2024-02

2. A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients;Frontiers in Medicine;2023-06-14

3. Extracellular vesicle DNA from human melanoma tissues contains cancer-specific mutations;Frontiers in Cell and Developmental Biology;2022-12-01

4. Evaluating the Diagnostic Potentials of Circulating Tumor DNA against Melanoma: A Systematic Review and Meta-Analysis;Journal of Oncology;2022-10-12

5. Diagnostic mutationnel rapide Idylla™ : applications théranostiques actuelles et futures;Annales de Pathologie;2022-07